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Abstract 
Background: The possibility of using deep brain stimulation (DBS) for memory enhancement has recently been 
reported, but the precise underlying mechanisms of its effects remain unknown. Our previous study suggested 
that spatial memory improvement by medial septum (MS)-DBS may be associated with cholinergic regulation and 
neurogenesis. However, the affected stage of memory could not be distinguished because the stimulation was 
delivered during the execution of all memory processes. Therefore, this study was performed to determine the stage 
of memory affected by MS-DBS. Rats were administered 192 IgG-saporin to lesion cholinergic neurons. Stimulation 
was delivered at different times in different groups of rats: 5 days before the Morris water maze test (pre-stimulation), 
5 days during the training phase of the Morris water maze test (training-stimulation), and 2 h before the Morris water 
maze probe test (probe-stimulation). A fourth group of rats was lesioned but received no stimulation. These four 
groups were compared with a normal (control) group.
Results: The most effective memory restoration occurred in the pre-stimulation group. Moreover, the pre-stimulation 
group exhibited better recall of the platform position than the other stimulation groups. An increase in the level of 
brain derived neurotrophic factor (BDNF) was observed in the pre-stimulation group; this increase was maintained for 
1 week. However, acetylcholinesterase activity in the pre-stimulation group was not significantly different from the 
lesion group.
Conclusion: Memory impairment due to cholinergic denervation can be improved by DBS. The improvement is sig-
nificantly correlated with the up-regulation of BDNF expression and neurogenesis. Based on the results of this study, 
the use of MS-DBS during the early stage of disease may restore spatial memory impairment.
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Background
Several therapies have been investigated in response to 
the growing prevalence of dementia. Several studies have 
reported that deep brain stimulation (DBS) of memory-
associated brain structures is a promising potential treat-
ment for dementia. Hypothalamic/fornix-DBS enhances 
some memory functions and modulates limbic activity 
[1, 2]. Entorhinal DBS during learning improves spa-
tial memory [3]. Nucleus-basalis-of-Meynert-DBS also 
enhances cognitive function in patients with Parkinson 
patients [4]. However, the mechanism by which DBS 
enhances memory remains unclear. Therefore, animal 
studies that investigate these mechanisms are necessary.
Degeneration of cholinergic basal forebrain neurons, 
including those in the medial septum (MS), is a com-
mon feature of Alzheimer’s disease (AD) and vascular 
dementia, and has been correlated with cognitive decline 
[5, 6]. The MS projects its neuronal fibers, which include 
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cholinergic, gamma-aminobutyric acid-ergic (GABAe-
rgic), and glutamatergic fibers, to the hippocampus [7, 
8], and modulates hippocampal activity via acetylcho-
line, GABA, and glutamate release [9, 10]. Therefore, 
the current study was performed in a memory-impaired 
rat model with cholinergic denervation. In our previous 
study, we showed that 2 weeks of MS-DBS improved spa-
tial memory in a memory-impaired rat model [11]. The 
results of this previous experiment suggest that spatial 
memory improvement by MS-DBS may be associated 
with cholinergic regulation and neurogenesis. However, 
the affected stage of memory (i.e., acquisition, consoli-
dation, or retrieval) could not be distinguished because 
the stimulation was delivered while all memory processes 
were undergoing. In this study, to detect the stage of the 
memory process affected by MS-DBS, stimulation was 
delivered at different time intervals: 5  days before the 
Morris water maze test (pre-stimulation), 5 days during 
the training phase of the Morris water maze test (train-
ing-stimulation), 2 h before the Morris water maze probe 
test (probe-stimulation). Determination of the stage 
of memory affected by DBS can help identify the most 




This study was performed in accordance with the guide-
lines for the care and use of laboratory animals of the 
Institutional Animal Care and Use Committee of Yon-
sei University (IACUC number: 2014-0206). Rats were 
housed in a temperature- and humidity-controlled room 
with a 12:12 h light/dark cycle, and all rats had free access 
to food and water.
Eight weeks old forty-one male Sprague-Dawley rats 
(200–250  g) were randomly assigned to one of the five 
groups. Rats in the normal group (n = 8) underwent no 
surgical procedures. Rats in the lesion group (n = 8) and 
all stimulation groups received intraventricular admin-
istration of 192 IgG-saporin. In addition, rats in all the 
stimulation groups had an electrode implanted in their 
MS. Rats in the pre-stimulation group (n =  9) received 
stimulation for 5  days prior to the Morris water maze 
training. Rats in the training-stimulation group (n =  9) 
received stimulation for 5 days during the training phase 
of the Morris water maze test. Rats in the probe-stimula-
tion group (n = 7) received stimulation for 2 h before the 
Morris water maze probe test.
Surgical procedure and stimulation parameters
Thirty-three rats were anesthetized with a mixture of keta-
mine (75 mg/kg), acepromazine (0.75 mg/kg), and rompun 
(4 mg/kg) and secured in a stereotaxic frame. After a scalp 
incision, rats were injected bilaterally with 8 µl of 192 IgG-
saporin (0.63 µg/µl, Chemicon, Temecula, CA, USA) at the 
cerebroventricle based on the following coordinates from 
the bregma: anterior posterior (AP): −0.8 mm, medial lat-
eral (ML): ±1.2  mm, dorsal ventral (DV): −3.4  mm. The 
solution was delivered at a rate of 1 µl/min using a syringe 
pump (Legato 130, KD Scientific, Holliston, MA, USA). 
The syringe was left in place for 5 min after the injection. 
After the administration of 192 IgG-saporin, 25 rats (all 
stimulation groups) underwent an additional procedure for 
electrode implantation. A hole was drilled in the skull at the 
level of the MS (AP: +0.6 mm, ML: 0.1 mm, DV: −6 mm 
from the bregma), and a unipolar tungsten electrode 
(254 µm diameter, A-M systems, Sequim, WA, USA) was 
implanted in the MS. The stimulation electrode was fixed 
with dental cement (Lang Dental Manufacturing, Wheel-
ing, IL, USA). Following surgery, wounds were treated daily 
with Betadine. If a rat had an infection following surgery, 
cefazolin (4 mg/100 g) was administered intravenously for 
3 days. The electrode was connected to a stimulator (Pulse-
master A300, stimulus isolator A365, WPI, Worcester, MA, 
USA). Electrical stimulation consisted of pulses (120  µs, 
100  µA) delivered at 60  Hz. Stimulation was delivered as 
shown in the schematic diagram in Fig. 1. The Pre-stimula-
tion group was stimulated for 5 consecutive days before the 
training phase (2  h/day). The training-stimulation group 
was stimulated for 5 consecutive days during training (after 
daily the last trial, 2  h/day). The probe-stimulation group 
was stimulated for 2 h just before probe test.
Morris water maze
Two weeks after surgery, rats performed the Morris 
water maze test as previously described [11]. The water 
maze consisted of a circular pool (2 m in diameter) filled 
with dark water (0.5  m in depth, 25  °C) and a circular 
black escape platform (0.15  m in diameter) submerged 
2 cm below the water surface. The maze tank was located 
in a dimly lit room with triangular, circular, and square-
shaped spatial cues in three quadrants. Rats were placed 
in the behavioral room for habituation 30 min before test-
ing. All the rats were trained for 5 consecutive days (4 tri-
als/day) with the platform in a fixed position. For each 
training trial, the rat was given 60 s to reach the platform. 
Any rat that did not reach the platform within 60 s was 
led to the platform by the experimenter and allowed to 
remain on the platform for 10 s. After 48 h from the final 
training trial, the rats were given a 60 s probe trial with-
out the platform in the pool. Swim paths were recorded 
using a video tracking system.
Acetylcholinesterase (AChE) assay
Immediately after the behavioral test, 5 out of 8 rats from 
the normal group, 4 out of 8 rats from the lesion group, 
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5 out of 9 rats from the pre-stimulation group, 4 out of 
9 rats from the training group, and 3 out of 7 rats from 
the probe group were anesthetized and the brains were 
quickly removed to acquire proteins. The frontal cortex 
(FC, including the cingulate cortex and prelimbic cortex), 
MS, diagonal band (DB) and hippocampus were dissected 
with fine forceps from 1  mm thick coronal brain slices. 
The tissues were homogenized in lysis buffer (Intron, 
Seongnam, Korea) on ice for 30 min and then centrifuged 
for 20 min at 12,000 rpm. The protein in the supernatant 
was measured using the bicinchoninic acid protein assay 
reagent kit (Pierce, Rockford, IL, USA). The protein sam-
ples were stored at −70 °C until analysis. The activity of 
AChE was determined using the method of Ellman et al. 
[12] with some modifications as previously described. 
In brief, 20  µl triplicate samples were mixed with the 
reaction mixture of 0.2  mM dithiobisnitrobenzoic acid 
(Sigma, Louis, MO, USA), 0.56  mM acetylthiocholine 
iodide (Sigma), 10 µM tetraisopropylpyrophosphoramide 
(Sigma), and 39 mM phosphate buffer (pH 7.2) at 37  °C 
for 30 min. The optical density was measured at 405 nm.
Western blotting
The protein sample was the same as the sample used 
for the AChE assay. Proteins were separated by 10–15% 
sodium-dodecyl-sulfate–polyacrylamide gels (SDS-
PAGE) and transferred onto polyvinylidene fluoride 
membranes. Membranes were blocked using blocking 
buffer (5% non-fat dry milk in phosphate buffered saline 
containing 0.05% Tween 20, PBST) for an hour at room 
temperature. The membranes were then incubated with 
primary antibodies overnight at 4  °C. Then, the corre-
sponding secondary antibodies were applied for 1  h at 
room temperature. Protein was detected with enhanced 
chemiluminescence solution (GE Healthcare Life Sci-
ences, Uppsala, Sweden) and LAS 4000 mini (GE Health-
care Life Sciences). The intensity of each band was 
measured using an analysis system (Multi Gauge version 
3.0; Fujifilm, Tokyo, Japan). The list of primary antibod-
ies included brain-derived nerotrophic factor (BDNF, 
1:1000; Millipore, Temecula, CA), glutamate decarboxy-
lase 65/67 (GAD, 1:1000; Millipore) and ß-actin (1:5000; 
Sigma).
Histology
Three out of 8 rats from the normal group, 4 out of 8 rats 
from the lesion group, 4 out of 9 rats from the pre-stimu-
lation group, 5 out of 9 rats from the training group, and 
4 out of 7 rats from the probe group were anesthetized 
and perfused with normal saline and cold 4% paraform-
aldehyde. The brains were stored in 4% paraformalde-
hyde for 3 days at 4 °C and transferred to 30% sucrose for 
3  days. Then the brain sections, which were sliced into 
30-µm thickness, were stored in a cryoprotectant solu-
tion. (0.1  M phosphate buffer, pH 7.2, 30% sucrose, 1% 
polyvinylpyrrolidone, and 30% ethylene glycol) at −20 °C. 
Anatomical landmarks from a stereotaxic atlas were used 
to localize the MS and hippocampus [13].
Cresyl violet staining was performed to confirm the elec-
trode location. The sections were soaked into Cresyl vio-
let for 2–5  min. Fluorescence immunohistochemistry was 
performed to detect cholinergic neurons and neurogen-
esis. Sections were blocked with 10% normal horse serum 
(Vector Labs, Burlingame, CA, USA) and incubated with 
primary antibodies at the following dilutions: choline acetyl-
transferase (ChAT, 1:50; Chemicon, Temecula, CA, USA), 
Sex-determining region Y-Box2 (Sox2, 1:50; Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA), DCX (1:50; Santa 
Cruz Biotechnology Inc.). After the primary immunoreac-
tion, sections were incubated with secondary antibodies 
conjugated with Cy3 (1:400; Jackson ImmuonReserch, West 
grove, PA, USA) or fluorescein (1:400; Thermo, Rockford, 
IL, USA). Staining on sections was visualized with LSM 700 
confocal microscope (Carl Zeiss, Jena, Germany).
Fig. 1 Schematic diagram of the stimulation and behavioral test timing. The pre-stimulation group received stimulation for 5 days prior to the 
water maze training. The Morris training-stimulation group received stimulation for 5 days during the Morris water maze training phase. The probe-
stimulation group received stimulation for 2 h shortly before the Morris water maze probe test
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Statistical analysis
A one-way analysis of variance (ANOVA) was used to 
analyze data from all trials. To evaluate the extent of 
spatial memory disruption, one-way ANOVAs were 
used to compare the groups receiving DBS at different 
time points for latency to reach the platform (training 
phase), time spent in the target quadrant, time spent in 
the platform zone, and the number of platform cross-
ings. Using these comparisons between the groups, 
we aimed to confirm that spatial memory is impaired 
by 192 IgG-saporin, while DBS delivered at different 
times can lead to memory improvements. The number 
of ChAT immunopositive cells was counted in 8 coro-
nal sections per group, located 0.7–1.2 mm posterior to 
the bregma (immunohistochemistry). The number of 
Sox2- and DCX-immunopositive cells was counted in 8 
coronal sections per group, located 3.0–3.6  mm poste-
rior to the bregma (immunofluorescence). The number 
of ChAT-, DCX- and Sox2-immunopositive cells are pre-
sented as the mean ± standard error of the mean (SEM). 
The results of the western blotting were normalized to 
β-actin for each sample and expressed as a percentage of 
the control values. One way ANOVA followed by a post 
hoc least significant difference test was used at each time 
point for statistical analysis. P-values less than 0.05 were 
considered statistically significant. All statistical analyses 
were performed with SPSS version 21 (IBM Corporation, 
Armonk, New York, USA).
Results
Cholinergic denervation and electrode location
Cholinergic denervation was evaluated by counting 
ChAT immunopositive cells (red) in the MS (Fig. 2). The 
number of ChAT immunopositive neurons in the nor-
mal group was 95.8 ± 10.14. Cholinergic neurons in the 
normal group were evenly distributed in the MS. In con-
trast, the number of cholinergic neurons in the groups 
injected with 192 IgG-saporin was significantly lower 
(F4,32  =  14.6, p  <  0.0001). The numbers of cholinergic 
neurons in lesion, pre-stimulation, training-stimulation, 
and probe-stimulation groups were 24 ± 5.5, 27.75 ± 6.7, 
and 36.57 ± 5.0 respectively. There wasn’t any noticeable 
change caused by stimulation. The location of the stimu-
lating electrodes in the MS was confirmed by Cresyl vio-
let staining (Fig. 3).
Spatial memory is enhanced by stimulation prior 
to training
The results of the Morris water maze training are shown 
in Fig. 4a. In all groups, the escape latency decreased from 
the first day to the last day of training (from over 30 s to 
less than 17 s). These data demonstrate progressive learn-
ing of the hidden platform location. In the Morris water 
maze probe test, the speed (Fig.  4b) and time spent in 
the target quadrant (Fig. 4c) were not significantly differ-
ent between the groups (F4,36 = 0.79, p > 0.5). However, 
it is appears that there was spatial memory impairment 
associated with the cholinergic deficit, as evidenced by 
the time spent in the target quadrant and the number 
of platform crossing. The amount of time in the plat-
form zone significantly decreased (F4,36 = 1.93, p < 0.05) 
to 15% of the normal group values in the lesion group 
(*p = 0.028), whereas it only decreased to 72% (p = 0.44) 
and 66% (p = 0.38) of the normal group for the training-
stimulation and probe-stimulation groups, respectively. 
The pre-stimulation group spent a similar amount of 
time as the normal group (1.04 s, p = 0.8) in the platform 
zone. Moreover, the pre-stimulation group significantly 
spent more time than lesion group (†p  <  0.05, Fig.  4d). 
The mean number of platform crossings was 2.25 ± 0.5 
in the normal group and 0.37 ±  0.3 in the lesion group 
(F4,36 = 2.09, *p = 0.018). In comparison, the mean num-
ber of platform crossing was 2.11 ± 0.4, 1.88 ± 0.5, and 
1.28 ±  0.5 for the pre-stimulation, training-stimulation, 
and probe-stimulation groups, respectively (Fig. 4e). The 
number of platform crossing was significantly improved 
in the pre-stimulation and training-stimulation groups 
compared with that in the lesion group (†p < 0.05).
Cholinergic denervation reduces AChE activity
There was no restoration of AChE activity associated 
with MS-DBS, except in the MS and DB of the probe-
stimulation group as shown in Fig. 5. AChE activity was 
significantly reduced in the FC (F4,10 = 10.5, p < 0.001) of 
the lesion (p = 0.03), pre-stimulation (p < 0.0001), train-
ing-stimulation (p < 0.05), and probe-stimulation groups 
(p < 0.05) compared with that in the normal group. AChE 
activity also was significantly reduced in the MS and DB 
(F4,10  =  8.9, p  =  0.002) of the lesion (p  =  0.002), pre-
stimulation (p = 0.002), and training-stimulation groups 
(p =  0.007) but was similar to the normal group in the 
probe-stimulation group. AChE activity in the hippocam-
pus of the lesion (p  <  0.001) and all stimulation groups 
(p  <  0.001) was significantly lower than in the normal 
group (F4,10 = 32.7, p < 0.0001).
Changes in GAD65/67 and BDNF expression
Western blotting was also performed to measure the 
changes in the expression of GAD65/67 and BDNF as 
a function of the stimulation time (Fig.  6). The level of 
GAD65/67 was measured to determine the activity level 
of GABAergic neurons, which are one of the main com-
ponents in the projection from the basal forebrain to the 
hippocampus. The expression level of GAD65/67 was 
not significantly different in the FC, MS, and DB with 
the lesion group or stimulation groups compared with 
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the normal group. However, the hippocampal expres-
sion level of GAD65/67 was markedly lower (F4,25 = 5.86, 
p  <  0.05) than that in the normal group in the pre-
stimulation (p  <  0.001), training-stimulation (p  <  0.05), 
and probe-stimulation groups (p  <  0.05). The expres-
sion level of BDNF increased in all groups that received 
stimulation. In the FC, the level of BDNF significantly 
increased regardless of the stimulation time (F4,25 = 2.81, 
p < 0.05). The highest levels of BDNF in the MS, DB, and 
hippocampus were expressed in the probe-stimulation 
group. The expression level was higher in the training-
stimulation group compared with the pre-stimulation. 
However, these differences were not significant (p > 0.05).
Neurogenesis is enhanced by stimulation prior to training
To evaluate the effect of time dependent MS-DBS on 
neurogenesis and differentiation, neuronal progenitor 
cells (Sox2) and neuroblasts or post-mitotic immature 
neurons (DCX) were quantified (Fig.  7). A significant 
decrease in the number of Sox2 (F4,26 = 5.35, p < 0.0001), 
Fig. 2 Representative images showing cholinergic lesions after the injection of 192 IgG-saporin. a Atlas schematic showing the medial septum. The 
square indicates the location at which the images were taken. b The normal group exhibited a large number of choline acetyltransferase (ChAT)-
immunopositive neurons (red) in the medial septum. The lesion groups (c) and all the stimulation groups (d pre-stimulation, e training-stimulation, 
f probe-stimulation), which were all injected with 192 IgG-saporin, exhibited a loss of ChAT-immunopositive neurons. g The number of ChAT-immu-
nopositive neurons was significantly reduced by 192 IgG-saporin (p < 0.05)
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and DCX (F4,25  =  2.09, p  <  0.05) immunopositive cells 
was observed in the lesion group compared with that 
in the normal group (57.3 and 65.7%, respectively). A 
slight decline in the number of Sox2 and DCX cells was 
observed in the pre-simulation and training-stimulation 
groups compared with that in the normal group, but 
Fig. 3 Location of electrodes. A representative stained section and an atlas schematic demonstrating the location of electrodes in the medial 
septum (MS) are shown. a The location of the stimulating electrodes was confirmed using Cresyl violet staining. The arrowheads indicate the tract 
of the electrode. b The population of electrode locations on an atlas schematic of MS, where circle indicates the location of electrodes in the pre-
stimulation group, diamond indicates the location of electrodes in the training-stimulation group, and triangle indicates the location of electrodes in 
the probe-stimulation group
Fig. 4 Effects of MS-DBS on spatial memory based on the stimulation time. a All the groups gradually acquired the location of the platform. After 
48 h from the last training trial, all the groups were administered a probe test. b The speed was not different among the groups. c The time spent 
in the target quadrant (in which the platform was placed) was slightly decreased in all the lesion groups. d The time spent in the platform zone (in 
which the platform was placed, 0.15 m in diameter) was significantly decreased in the group with cholinergic lesions compared with normal group 
(*p = 0.02). However, the time spent in this zone was increased by stimulation. The time spent of pre-stimulation group was significantly increased 
than lesion group (†p < 0.05). e The number of platform crossings was also reduced in the cholinergic lesion group and increased in all stimulation 
groups
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these differences were not significant. The proportion of 
Sox2- and DCX-immunopositive cells compared with 
that in the normal group were 90.9 and 78.4%, respec-
tively, for the pre-stimulation group and 85.5 and 75.5%, 
respectively, for the training-stimulation group. In con-
trast, the number of Sox2 (F4,26  =  5.35, p  <  0.05), and 
DCX (F4,25 =  2.09, p  <  0.05), immunopositive cells was 
significantly lower in the probe-stimulation group com-
pared with that in the normal group (72.9 and 60.5%, 
respectively).
Discussion
This study, which was performed to identify the stage of 
memory at which MS-DBS is the most effective, revealed 
that MS-DBS prior to training on the Morris water maze 
test was the most effective in inducing memory enhance-
ment. This memory enhancement may be due mainly to 
the increase of BDNF expression that was induced by the 
stimulation. Our study concurs with a clinical study that 
reported a favorable effect of DBS on disease progression 
and cognitive function when administered in the early 
stage of AD [14]. According to the results of the behavio-
ral test, all stimulation time point improved spatial mem-
ory, and there were differences in the intensities of these 
changes. Our understanding of these processes could be 
improved by further research with various animal models 
and behavioral tests.
DBS increased BDNF expression mainly in the FC. In 
addition, increased BDNF expression was maintained for 
1 week after the cessation of stimulation. Differences in 
BDNF expression levels at the stimulation site could be 
induced by altering the interval between stimulation and 
sampling. Levels of BDNF in the frontal cortex are cor-
related with working memory performance [15]. Further-
more, it has been reported that electrical stimulation in 
this region is associated with BDNF release [16]. BDNF 
plays a critical role in modulating various neural func-
tions such as membrane excitability, activity-dependent 
synaptic plasticity, and neurogenesis [17, 18]. Therefore, 
increasing the level of BDNF using MS-DBS could lead 
to improved spatial memory. However, it remains unclear 
what factors determine the level of BDNF expression in 
different regions.
Hippocampal neurogenesis is thought to be associated 
with hippocampus-dependent memory [19]. In addition, 
it has been reported that cholinergic forebrain lesions 
decrease neurogenesis [20]. The results of this study sup-
port the hypothesis that DBS rescues decreased neuro-
genesis induced by cholinergic lesions. Sox2 is expressed 
in the adult brain in proliferating precursor cells [21, 22]. 
DCX is also expressed in late mitotic neuronal precur-
sors and early post-mitotic neurons [23, 24]. The num-
bers of Sox2- and DCX-immunopositive neurons were 
reduced by the administration of 192 IgG-saporin. Inter-
estingly, the numbers recovered with pre-stimulation and 
training-stimulation, which suggest that DBS promotes 
neurogenesis in the hippocampal dentate gyrus (DG). 
However, 2  h of MS-DBS was not sufficient to improve 
neurogenesis, which may be due to the short time inter-
val between stimulation and sacrifice.
Two major neurotransmitter systems of the MS, 
GABA and acetylcholine regulate hippocampal activity 
and memory [9, 10]. Moreover, Acetylcholine depresses 
GABAergic interneurons in the hippocampus [25]. The 
memory impaired rat model in this experiment was 
induced by selectively damaging cholinergic neurons in 
the basal forebrain (including MS and nucleus basalis 
Meynert), and hippocampus [26]. Therefore, neuronal 
activity in the hippocampus could be suppressed by the 
intact GABAergic and damaged cholinergic systems. MS-
DBS might regulate the balance between damaged cho-
linergic and intact GABAergic neurons. As evidenced of 
decreased GAD expression in the hippocampus, it is also 
Fig. 5 Changes in acetycholinesterase (AChE) activity. a AChE activity 
in the frontal cortex. AChE activity was significantly reduced in the 
lesion group and all the stimulation groups compared with that in 
the normal group. b AChE activity in the medial septum and diagonal 
band. AChE activity was restored only in the probe-stimulation group. 
c AChE activity in the hippocampus. Hippocampal AChE activity 
was significantly reduced in the lesion group and all the stimula-
tion groups compared with the normal group. AChE activity was 
expressed as the optical density at 405 nm (values represent the 
mean ± SEM, p < 0.05)
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assumed that hippocampal GABAergic suppression by 
MS-DBS is involved in memory restoration. In addition, 
GABAergic regulation of neuronal architecture has been 
reported. A hippocampal GABAA receptor agonist has 
been shown to impair spatial memory [27]. Prior studies 
in mutant mice have shown that enhanced GABAB recep-
tor activity reduces the expression of immediate-early 
genes that encode the protein activity-regulated cytoskel-
eton-associated protein (Arc) which is essential for syn-
aptic plasticity and memory [28, 29]. Therefore, spatial 
memory restoration may change synaptic plasticity by 
suppressing GABAergic activity.
Limitations of Study
Recently, Lee et al. (2016) have suggested a specific ben-
efit of theta frequency stimulation in traumatic brain 
injury. Stimulation at 7.7  Hz stimulation in the medial 
septum improved object exploration and increased hip-
pocampal theta oscillation in adult male Harlan Sprague-
Dawley rats. However, 100  Hz gamma stimulation did 
not enhance performance [30]. Prior to our main study, 
we had performed a preliminary experiment (data not 
shown) to investigate the effects of different currents (50 
or 100 µA) and different frequencies (10, 60, 130 Hz). In 
the preliminary experiment, some rats receiving low-
frequency stimulation developed convulsions. In con-
trast, Lee et  al. (2016) reported that continuous theta 
and gamma stimulation did not elicit side effects. This 
inconsistency may result from differences between the 
studies in frequency and disease condition. Therefore, as 
we only used one frequency (60 Hz), this should be con-
sidered in the interpretation of our results. In addition, 
different groups of rats did not receive the same duration 
of stimulation (2  h/day for 5  days versus only 2  h). Lee 
et  al. (2016) have previously reported that there was no 
effect of stimulation duration on spatial learning in brain-
injured rats. However, it is not clear whether the differ-
ences we observed between groups in this study resulted 
from stimulation timing or stimulation duration Future 
studies should avoid these limitations by investigating 
Fig. 6 Changes in glutamate decarboxylase (GAD) 65/67 and brain-derived neurotrophic factor (BDNF) expression. The expression level of GAD 
65/67 was not significantly different in the frontal cortex (FC) (a) or medial septum (MS) and diagonal band (DB) (b) for all the groups compared 
with that in the normal group. c The hippocampal level of GAD 65/67 was significantly lower relative to the normal group at all stimulation times. d 
Representative western blotting results. e The expression level of BDNF was significantly higher in all the stimulation groups in the FC. BDNF expres-
sion also was slightly higher in the MS and DB (f) and hippocampus (g). h Representative western blotting results. The indices are expressed as a 
percentage of values for the normal group (mean ± SE, p < 0.05)
(See figure on next page.) 
Fig. 7 Effects of time-dependent MS-DBS on adult hippocampal neurogenesis. a Representative immunofluorescence images reveal the effects 
of time-dependent MS-DBS on neurogenesis and differentiation. Hippocampal dentate gyrus (DG) sections stained for Sox2 (red), DCX (green), 
and DAPI (blue) are shown. The number of Sox2- (b) and DCX-immunopositive cells (c) was significantly lower in the lesion and probe-stimulation 
groups than in the normal group. However, the numbers of Sox2- and DCX-immunopositive cells were elevated in the pre- and training-stimulation 
groups (values represent the mean ± SEM, p < 0.05)
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various stimulation frequencies and ensuring that the 
same stimulation duration is used across groups. In 
addition, we cannot clearly explain how MS-DBS down-
regulate hippocampal GABAergic activity. To better 
understand, more exploring in the other lesion sites and 
neurotransmitters system is needed.
Conclusion
MS-DBS (60  Hz, 120  μs, 100  μA) restored spatial mem-
ory impairment by increasing the BDNF level, which 
is associated with neuronal activity and neurogenesis. 
The pre-stimulation group may have exhibited the most 
enhancement in memory because it had the longest period 
of increased BDNF. The enhanced spatial memory associ-
ated with DBS might mainly result from increased BDNF 
level in rather than from direct electrical stimulation of 
cholinergic or GABAergic neurons. Based on the results 
of this study, we propose the use of DBS during the early 
stage of disease to restore spatial memory impairments.
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